We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
-6.11%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$159M
AUM Growth
-$11.4M
Cap. Flow
+$646K
Cap. Flow %
0.41%
Top 10 Hldgs %
38.61%
Holding
104
New
6
Increased
26
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
DENN
Denny's
DENN
+$896K
2
AMZN icon
Amazon
AMZN
+$578K
3
MRK icon
Merck
MRK
+$308K
4
QCOM icon
Qualcomm
QCOM
+$267K
5
AAPL icon
Apple
AAPL
+$133K

Sector Composition

Rank Sector Weight
1 Healthcare 20.68%
2 Technology 20.43%
3 Industrials 15.55%
4 Financials 15.49%
5 Consumer Staples 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
26
Eaton
ETN
$157B
$1.99M 1.25%
14,922
-115
-0.8% -$16.1K
CBRE icon
27
CBRE Group
CBRE
$40.8B
$1.97M 1.24%
29,198
-75
-0.3% -$5.95K
LMT icon
28
Lockheed Martin
LMT
$134B
$1.96M 1.23%
5,075
TRP icon
29
TC Energy
TRP
$73.5B
$1.9M 1.19%
47,153
-98
-0.2% -$4.86K
MLM icon
30
Martin Marietta Materials
MLM
$33.6B
$1.89M 1.19%
5,875
-130
-2% -$44K
MSFT icon
31
Microsoft
MSFT
$2.84T
$1.81M 1.13%
7,753
+200
+3% +$52.8K
CI icon
32
Cigna
CI
$76.6B
$1.74M 1.09%
6,262
BKNG icon
33
Booking.com
BKNG
$138B
$1.72M 1.08%
26,175
+500
+2% +$37.6K
V icon
34
Visa
V
$677B
$1.7M 1.07%
9,572
SYF icon
35
Synchrony
SYF
$23.7B
$1.7M 1.06%
60,212
BAX icon
36
Baxter International
BAX
$11.6B
$1.62M 1.02%
30,142
-5,156
-15% -$310K
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$121B
$1.52M 0.95%
5,235
-10
-0.2% -$2.88K
CVS icon
38
CVS Health
CVS
$137B
$1.5M 0.94%
15,671
+2
+0% +$198
J icon
39
Jacobs Solutions
J
$15.9B
$1.48M 0.93%
16,435
HSY icon
40
Hershey
HSY
$35.4B
$1.31M 0.82%
5,960
+1
+0% +$224
STZ icon
41
Constellation Brands
STZ
$22.2B
$1.31M 0.82%
5,706
+301
+6% +$73.4K
AMZN icon
42
Amazon
AMZN
$2.5T
$1.17M 0.73%
10,350
+4,575
+79% +$578K
JNJ icon
43
Johnson & Johnson
JNJ
$635B
$1.17M 0.73%
7,148
PRU icon
44
Prudential Financial
PRU
$41.7B
$1.07M 0.67%
12,516
+802
+7% +$77.2K
MRK icon
45
Merck
MRK
$324B
$1.03M 0.65%
11,970
+3,450
+40% +$308K
MDT icon
46
Medtronic
MDT
$107B
$1.03M 0.65%
12,755
+1,102
+9% +$99K
QCOM icon
47
Qualcomm
QCOM
$176B
$912K 0.57%
8,070
+1,945
+32% +$267K
COO icon
48
Cooper Companies
COO
$13.7B
$888K 0.56%
13,460
+1,200
+10% +$91.9K
DENN
49
DELISTED
Denny's
DENN
$879K 0.55%
+93,456
New +$896K
BCE icon
50
BCE
BCE
$19.9B
$856K 0.54%
20,400

Similar funds

Lipe & Dalton's Q3 2022 Portfolio in Review

As of Q3 2022, Lipe & Dalton held 104 positions worth $159M, down 6.7% from $171M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lipe & Dalton's Q3 2022 filing shows 6 new, 26 increased, 21 reduced and 2 closed positions. Its largest new stake was Denny's: 93,456 shares worth $879K. The largest sale was ScottsMiracle-Gro, an estimated $944K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Lipe & Dalton's largest Q3 2022 buy was Denny's: 93,456 shares worth $879K.
  • Lipe & Dalton added most to Amazon in Q3 2022, an estimated $578K increase.
  • Lipe & Dalton's biggest Q3 2022 reduction was Boeing, cutting an estimated $399K.
  • Lipe & Dalton fully exited ScottsMiracle-Gro in Q3 2022, selling an estimated $944K.
  • Lipe & Dalton's ten largest holdings make up 39% of its $159M portfolio in Q3 2022.
  • Lipe & Dalton opened 6 new positions and closed 2 in Q3 2022.
  • Lipe & Dalton's portfolio value fell 6.7% quarter-over-quarter to $159M.

Based on Lipe & Dalton's 13F filing for Q3 2022, filed 7 Nov 2022.